Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 240 is classified as a pseudogene for RN7SK, which means it is a non-functional genomic sequence similar to the functional 7SK small nuclear RNA gene. This pseudogene does not encode a protein or functional RNA product and has no known biological function, disease association, or therapeutic relevance. Therefore, it is not considered a therapeutic target[1][3]. Reliable functional and clinical information exists only for the active RN7SK gene and its ribonucleoprotein complex, not for this specific pseudogene. This entry is for a pseudogene (RN7SKP240) and not for a functional gene or protein target. The functional RN7SK gene encodes a non-coding RNA involved in transcription regulation and various cellular processes, but RN7SKP240 has not been reported to carry any known function or clinical relevance in current knowledge[1][3][5]. If your focus is on the functional RNA (RN7SK), additional details are available, but RN7SKP240 itself is not a target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 240 (RN7SKP240).